Metronomics Global Health Initiative

Home page > People > Ambassadors > Shripad BANAVALI


Pr. Shripad D. Banavali MD (Med; Bom), BC(Ped; USA)),BE(Hem-Onc; USA) Professor & Head, Department of Medical & Pediatric Oncology Dr. Ernest Borges Road, Parel, Mumbai - 400 012. INDIA

He did his MD in Internal Medicine in 1986 and underwent 3 years (1987-90) of Adult Oncology training at Tata Memorial Hospital, Mumbai under the able guidance of Dr S. H. Advani. During this period he wrote a research project on Chronic Myeloid Leukemia for which he got a Fellowship to work with Dr Harvey Priesler in Cincinati, USA. He spent nearly 3 years there, doing research on various aspects of leukemia and especially the CD 34 + hematogenic progenitor cells. In 1992, he moved to Memphis, Tennessee, USA to work at St. Jude Children’s Research Hospital which is considered the “Mecca” of Pediatric Oncology. Here he did his Board Certification in Pediatrics and Fellowship in Pediatric Hematology-Oncology. After spending 8 years in USA, he came back and joined Tata Memorial Hospital.

At present he is head of the Department of Medical & Pediatric Oncology at Tata Memorial Hospital. He has keen interest in leukemia cell biology, immunology, cell kinetics and Experimental Oncology. He has more than 200 scientific publications in various peer reviewed journals to his credit.

The most important challenge in cancer medicine in India is not finding a cure but developing effective and affordable therapies. Since accepting the helm of the medical oncology department in India’s largest and most advanced cancer hospital, Dr. Shripad Banavali has embraced a revolutionary approach to cancer treatment known as metronomic therapy. With this approach, well-proven chemotherapeutic agents are administered to patients at low doses at regular intervals over an extended period of time. The debilitating side effects of high-dose treatments are minimized and the treatment can be administered in smaller cancer centers with minimal supportive care.

Reply to this article


2 Forum messages

  1. Shripad BANAVALI

    I need assistance to contact Dr Banavali. I am a patient of Chronic Myeloid Leukemia since October 2011,under treatment at Rajiv Gandhi Cancer Institute, New Delhi. I am a female aged 54 years. I have become resistant to Imatinib and was advised to take Dasatinib. After taking Dasatinib 100mg for 2 months, my FISH BCR-ABL result showed 18.5% positivity, but now after total 4 months the results show 40% positivity.

    I would like to seek a consultation with Dr Banavali for my condition. Please assist to share his contact details.

    Thanks and regards

    by Meenakshi | 7 March 2013, 13:52

    Reply to this message

    1. Shripad BANAVALI


      Could you please send me your email to the email address mentioned in the Join In post, so i can forward your quesry to Pr Banavali.

      by Nicolas André | 12 March 2013, 14:56

      Reply to this message